Publications by authors named "Arnetha J Whitmore"

Background: Sutureless microvascular anastomosis has great translational potential to simplify microvascular surgery, shorten operative times, and improve clinical outcomes. The authors developed a transient thermoreversible microvascular stent using a poloxamer to maintain vessel lumen patency before application of commercially available adhesives to seal the anastomosis instead of sutures. Despite technical success, human application necessitates bovine serum albumin removal from existing formulations; rapid poloxamer transition between states; and increased stiffness for reliable, reproducible, and precise microvascular approximation.

View Article and Find Full Text PDF

Background: Endothelial progenitor cells have been shown to traffic to and incorporate into ischemic tissues, where they participate in new blood vessel formation, a process termed vasculogenesis. Previous investigation has demonstrated that endothelial progenitor cells appear to mobilize from bone marrow to the peripheral circulation after exercise. In this study, the authors investigate potential etiologic factors driving this mobilization and investigate whether the mobilized endothelial progenitor cells are the same as those present at baseline.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic patients with severe pressure ulcers often face serious health risks, including limb loss, mainly due to issues with wound healing.
  • A key problem in diabetes is that a specific factor (HIF-1α) that helps with wound healing doesn’t work well because of high sugar levels and other harmful substances in the body.
  • Researchers created a new skin patch with a drug called deferoxamine (DFO) that boosts HIF-1α activity, which helped heal wounds better and even prevented new ulcers in diabetic mice.
View Article and Find Full Text PDF

Scarring and tissue fibrosis represent a significant source of morbidity in the United States. Despite considerable research focused on elucidating the mechanisms underlying cutaneous scar formation, effective clinical therapies are still in the early stages of development. A thorough understanding of the various signaling pathways involved is essential to formulate strategies to combat fibrosis and scarring.

View Article and Find Full Text PDF